Abbott Laboratories

Investment oversight for the Abbott-AbbVie Multiple Employer Pension Plan rests with Abbott's treasury and investment committee functions, operating under the direction of the Chief Financial Officer. Philip Boudreau assumed the CFO role in May 2024, succeeding Robert Funck (per the firm). The committee allocates across a balanced mandate that includes buyout funds, distressed debt, growth equity, special situations, and co-investments. Specific external investment committee members or CIO-level pension staff have not been publicly identified.

The Abbott-AbbVie Multiple Employer Pension Plan pools participants from both Abbott Laboratories and AbbVie Inc., the research-based biopharmaceutical company spun off from Abbott in 2013. Both companies serve as co-sponsors under the plan documents. Each sponsor bears proportionate responsibility for its own employee obligations, but the pooled structure allows a single investment committee to manage the combined asset base — approximately $4B (Altss estimate).

The pension plan invests through commingled private equity, distressed debt, and venture debt funds rather than making standalone direct investments in individual operating companies. Any exposure to healthcare-sector companies would be through fund managers making portfolio-level decisions. Abbott's corporate development team and its venture arm maintain separate processes from the pension plan's investment activities, reducing the potential for conflicts.

The plan's strategy spans the full corporate lifecycle. It allocates to growth equity for earlier-stage companies, buyout funds targeting mature businesses, distressed debt for companies undergoing restructuring, and special situations mandates that cross traditional stage boundaries. The co-investment sleeve gives the plan discretion to increase exposure alongside existing GP relationships, typically in buyout or growth-stage transactions where the lead GP has already underwritten the deal.

The Abbott Fund and the Abbott Patient Assistance Foundation are corporate philanthropic entities, completely distinct from the pension plan's fiduciary investment activities. The Fund operates with its own governance, budget, and programmatic focus — primarily global health access, disaster relief, and community development. The pension plan's assets are held in trust solely for the benefit of plan participants and cannot be used for charitable purposes.

The plan's mandate explicitly includes co-investment, indicating an active posture alongside general partners. Co-investment typically allows the plan to deploy additional capital into specific deals without paying fund-level management fees or carried interest on those co-investment amounts. The strategy suggests the plan maintains relationships with private equity managers willing to offer co-investment rights, though specific GP names have not been publicly disclosed.

The plan uses a hybrid model — committing to external private equity, distressed debt, and venture debt funds as a limited partner while maintaining a co-investment sleeve for direct participation in individual deals sourced through those GP relationships. The balanced, buyout, and growth equity strategy designations indicate fund commitments form the core allocation, with co-investment serving as a supplementary tool for concentration and fee management.